Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
Sci Adv. 2023 Aug 9;9(32):eadg9832. doi: 10.1126/sciadv.adg9832.
Histone H2A lysine 119 (H2AK119Ub) is monoubiquitinated by Polycomb repressive complex 1 and deubiquitinated by Polycomb repressive deubiquitinase complex (PR-DUB). PR-DUB cleaves H2AK119Ub to restrict focal H2AK119Ub at Polycomb target sites and to protect active genes from aberrant silencing. The PR-DUB subunits (BAP1 and ASXL1) are among the most frequently mutated epigenetic factors in human cancers. How PR-DUB establishes specificity for H2AK119Ub over other nucleosomal ubiquitination sites and how disease-associated mutations of the enzyme affect activity are unclear. Here, we determine a cryo-EM structure of human BAP1 and the ASXL1 DEUBAD in complex with a H2AK119Ub nucleosome. Our structural, biochemical, and cellular data reveal the molecular interactions of BAP1 and ASXL1 with histones and DNA that are critical for restructuring the nucleosome and thus establishing specificity for H2AK119Ub. These results further provide a molecular explanation for how >50 mutations in BAP1 and ASXL1 found in cancer can dysregulate H2AK119Ub deubiquitination, providing insight into understanding cancer etiology.
组蛋白 H2A 赖氨酸 119(H2AK119Ub)被多梳抑制复合物 1 单泛素化,并被多梳抑制去泛素化酶复合物(PR-DUB)去泛素化。PR-DUB 切割 H2AK119Ub 以限制 Polycomb 靶位点处的局部 H2AK119Ub,并防止活性基因发生异常沉默。PR-DUB 亚基(BAP1 和 ASXL1)是人类癌症中最常发生突变的表观遗传因子之一。PR-DUB 如何针对 H2AK119Ub 建立特异性,而不是针对其他核小体泛素化位点,以及酶的疾病相关突变如何影响活性尚不清楚。在这里,我们确定了人类 BAP1 和 ASXL1 DEUBAD 与 H2AK119Ub 核小体复合物的冷冻电镜结构。我们的结构、生化和细胞数据揭示了 BAP1 和 ASXL1 与组蛋白和 DNA 的分子相互作用,这些相互作用对于重塑核小体并因此针对 H2AK119Ub 建立特异性至关重要。这些结果进一步为 BAP1 和 ASXL1 中发现的 >50 种癌症突变如何失调 H2AK119Ub 去泛素化提供了分子解释,为理解癌症病因提供了线索。